Pharmaceuticals
-
Opioid risk for patients with pain conditions
The risk of long-term opioid use is increased among people with rheumatoid arthritis or fibromyalgia, a new study has found. Read more
-
Parkinson’s trial begins in Dundee
A project to test a new treatment for Parkinson’s disease has launched at the University of Dundee – with the recruitment of the first patient participant. Read more
-
No increased risk of menstrual changes after COVID-19 vaccine
There is no evidence of increased risk of menstrual changes after having the COVID-19 vaccine, according to a new Swedish study published today. Read more
-
Beta blockers may not cut second heart attack risk
The use of beta blockers to prevent a second heart attack is called into question by researchers today. Read more
-
Study backs cannabis pain relief for cancer patients
A study of medicinal cannabis for cancer patients has shown promising results, researchers report today. Read more
-
HIV drug could prevent build-up of toxic proteins in brain
A repurposed HIV drug can restore the brain’s ability to clear out toxic proteins, helping to prevent the dangerous build-up seen in Huntington’s disease and other neurological diseases, researchers reported last night. Read more
-
Little benefit from surgery for sciatica
Treating sciatica with surgery may not benefit patients over the long term, researchers reported last night. Read more
-
Promising therapy revealed for long COVID fatigue
A potential treatment for fatigue for people with long COVID shows promise after a phase 2 clinical trial, British researchers have reported. Read more
-
Vaccines prevented a million COVID deaths
In just over two years COVID vaccination has saved more than a million lives in Europe, according to a new analysis. Read more
-
Bivalent COVID-19 booster vaccine ‘effective’
The bivalent mRNA COVID-19 vaccine is effective in reducing the risk of hospitalisation or death among older people, according to one of the first studies to assess the vaccine. Read more